Medicare officials say program will continue to cover cost of controversial drug despite recent panel decision that Avastin is no good for treating breast cancer
Read More »Medicare officials say program will continue to cover cost of controversial drug despite recent panel decision that Avastin is no good for treating breast cancer
Read More »